BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12881865)

  • 1. [Perioperative changes in plasma endothelin and calcitonin gene-related peptide in congenital heart disease with pulmonary hypertension].
    Zhang ZW; Lin R; Li JH; Hu J; Wang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 32(3):212-4. PubMed ID: 12881865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in ET-1, Plasma Neuropeptide Y, and CGRP in Child Patients With Congenital Heart Disease Complicated With Pulmonary Hypertension Before and After Operation.
    Liu Z; Zhang M; Huo Q; Zhu T
    Clin Pediatr (Phila); 2021 Jan; 60(1):56-63. PubMed ID: 32814460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perioperative observation of plasma endothelin in patients with congenital heart disease with pulmonary hypertension underwent open heart surgery].
    Song FL; Luo HH; Liu F
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):379-80. PubMed ID: 12536745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease.
    Komai H; Adatia IT; Elliott MJ; de Leval MR; Haworth SG
    J Thorac Cardiovasc Surg; 1993 Sep; 106(3):473-8. PubMed ID: 8361190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation.
    Yoshibayashi M; Nishioka K; Nakao K; Saito Y; Matsumura M; Ueda T; Temma S; Shirakami G; Imura H; Mikawa H
    Circulation; 1991 Dec; 84(6):2280-5. PubMed ID: 1959183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood flow.
    Vincent JA; Ross RD; Kassab J; Hsu JM; Pinsky WW
    Am J Cardiol; 1993 May; 71(13):1204-7. PubMed ID: 8480647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the effect of adrenomedulin and urotensin-II on pulmonary hypertension of patients with congenital heart disease].
    Wang T; Li SX; Zhang XQ; Gu XH; Song Y; Zhang G; Wu SM
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(38):2691-5. PubMed ID: 16324296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
    Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
    Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between plasma endothelin, nitric oxide, calcitonin gene-related peptide levels and pulmonary hemodynamics in patients with chronic cor pulmonale].
    Bai C; Han Y; Liu Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):407-10. PubMed ID: 11326879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect and mechanism of felodipine on monocrotaline induced pulmonary hypertension in rats].
    Zeng Z; Huang H; Li X
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Aug; 25(8):461-4. PubMed ID: 12425830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alternation of the level of plasma calcitonin gene related peptide and endothelin-1 in liver cirrhosis].
    Zhan Q; Guo J; Tang J; Shao L
    Zhonghua Nei Ke Za Zhi; 1999 Feb; 38(2):91-3. PubMed ID: 11798632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The changes of plasma endothelin concentration and its clinical significance in pulmonary hypertension associated with congenital heart defects].
    Zhang S; Qi S; Shen X; Zhou S; Jin S
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(5):425-7. PubMed ID: 10073026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma endothelin 1 concentrations in children with congenital heart defects.
    Jia B; Zhang S; Chen Z; Li Z; Li X; Hui W; Ye M
    Minerva Pediatr; 1998 Apr; 50(4):99-103. PubMed ID: 9808961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of plasma endothelin-1 in young patients with pulmonary hypertension caused by congenital heart disease are decreased after successful surgical repair.
    Ishikawa S; Miyauchi T; Sakai S; Ushinohama H; Sagawa K; Fusazaki N; Kado H; Sunagawa H; Honda S; Ueno H
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):271-3. PubMed ID: 7609554
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of nitroglycerin on plasma calcitonin gene-related peptide and endothelin in congestive heart failure].
    Yu ZX; Ou SQ; Lü YZ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):251-4. PubMed ID: 14653081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating calcitonin gene-related peptide in congestive heart failure caused by congenital heart disease.
    Hsu JH; Yeh JL; Dai ZK; Chen IJ; Wu JR
    Int Heart J; 2005 Sep; 46(5):867-75. PubMed ID: 16272777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity.
    Allen SW; Chatfield BA; Koppenhafer SA; Schaffer MS; Wolfe RR; Abman SH
    Am Rev Respir Dis; 1993 Aug; 148(2):519-22. PubMed ID: 8342919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass.
    Pearl JM; Manning PB; McNamara JL; Saucier MM; Thomas DW
    Ann Thorac Surg; 1999 Oct; 68(4):1369-75. PubMed ID: 10543508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of tetramethylpyrazine on endothelin, von Willebrand factor and thromboxane A2 during cardiopulmonary bypass in patients of congenital heart disease with pulmonary hypertension].
    Huang RJ; Liao CX; Chen DZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Apr; 23(4):268-71. PubMed ID: 12764908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dynamic change of plasma endothelin-1 during the perioperative period in patients with rheumatic valvular disease and secondary pulmonary hypertension.
    Zhu ZG; Wang MS; Jiang ZB; Jiang Z; Xu SX; Ren CY; Shi MX
    J Thorac Cardiovasc Surg; 1994 Nov; 108(5):960-8. PubMed ID: 7967681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.